Acumen Pharmaceuticals, Inc. ($ABOS)
Filing Information
| Accession Number | 0001628280-26-002961 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 16, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
247,833
Total Value
$0.00
P&L
+inf% (+$723,672.36)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CFO & Chief Business Officer | Common Stock | โ | Jan 16, 2026 | Grant/Award | 99,133 | $0.00 | $0.00 | 309,084 | Direct | โ | View Details | |
CFO & Chief Business Officer | Employee Stock Option (right to buy) | Derivative | Jan 16, 2026 | Grant/Award | 148,700 | $0.00 | $0.00 | 148,700 | Direct | โ | View Details |